医学
氨氯地平
依那普利
心脏病学
内科学
血压
心肌梗塞
冠状动脉疾病
安慰剂
心绞痛
心力衰竭
冲程(发动机)
血管紧张素转换酶
替代医学
病理
机械工程
工程类
作者
Steven E. Nissen,E. Murat Tuzcu,Peter Libby,Paul M. Thompson,Magdi Ghali,Dahlia Garza,Lance Berman,Harry Shi,Ethel Buebendorf,Eric J. Topol,for the CAMELOT Investigators
出处
期刊:JAMA
[American Medical Association]
日期:2004-11-09
卷期号:292 (18): 2217-2217
被引量:1148
标识
DOI:10.1001/jama.292.18.2217
摘要
Administration of amlodipine to patients with CAD and normal blood pressure resulted in reduced adverse cardiovascular events. Directionally similar, but smaller and nonsignificant, treatment effects were observed with enalapril. For amlodipine, IVUS showed evidence of slowing of atherosclerosis progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI